Bio_Sole

About Bio_Sole

Bio-Sole operates at the intersection of biometric technology and personalized healthcare, developing intelligent wearables that transform movement into actionable health data. The company is a subsidiary of the Canadian biometric pioneer autonomous_ID Corporation, which was founded in 2007 by Todd Gray. Gray, who serves as the Principal Inventor and Strategist, originally conceived of the technology as a security measure for military applications after an attack in Iraq involving a friendly fire incident. The concept was to create a biometric signature from an individual's unique gait to confirm identity within a few steps.

The company's core product is the Bio-Sole, a patented, AI-powered smart insole. Unlike wrist-based wearables that primarily track step counts and heart rate, the Bio-Sole captures a more complex dataset, including gait patterns, balance, posture, and load-bearing metrics. This is accomplished through a combination of pressure sensors, an accelerometer, and a gyroscope embedded within the insole. The system's edge AI architecture processes this information to create a unique biometric profile, which the company refers to as a "PEDO_BIOMETRIC® signature" or the "6th vital sign." This allows for both continuous health monitoring and passive, privacy-first identity verification.

The business model targets several key markets. For healthcare, the technology enables remote patient monitoring, early detection of chronic diseases like Parkinson's or diabetes through subtle gait changes, and aids in rehabilitation. In elder care, it serves as a tool for fall prevention by tracking mobility and balance. The enterprise safety sector can use it for ergonomic risk detection. Furthermore, the insoles function as a biometric authentication solution for corporate and government security applications. A significant milestone occurred in May 2025, when Bio_Sole International Group Ltd., the U.S. subsidiary, acquired Atlantic Footcare, a Rhode Island-based insole manufacturer. This acquisition provides Bio-Sole with a high-capacity U.S. manufacturing hub, capable of producing over one million units per month, positioning the company for large-scale commercial rollout.